Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
13.43
-0.37 (-2.68%)
At close: Jul 20, 2026
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $53.03 billion as of July 20, 2026. Its market cap has increased by 67.37% in one year.
Market Cap
53.03B
Enterprise Value
89.93B
Revenue
52.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.43
ChartMarket Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 53.03B, an increase of 804.92%. That is a compound annual growth rate of 6.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 53.03B | 23.98% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Veradigm | 517.71M |
| Silence Therapeutics | 495.96M |
| Elite Pharmaceuticals | 418.18M |
| American Oncology Network | 404.79M |
| Glorywin Entertainment Group | 359.76M |
| CytoDyn | 291.78M |
| Northwest Biotherapeutics | 279.82M |